IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer
Clinical trial NCT01440816 · COMPLETED
Trial details
- NCT number
- NCT01440816
- Sponsor
- OncoSec Medical Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-03
- Primary completion
- 2015-04-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.